permethrin

(redirected from Acticin)
Also found in: Dictionary, Wikipedia.

permethrin

 [per-meth´rin]
a topical insecticide used in the treatment of scabies and head louse or tick infestation. It is also applied to objects such as furniture and bedding.

permethrin

/per·meth·rin/ (per-meth´rin) a topical insecticide used in the treatment of infestations by Pediculus humanus capitis, Sarcoptes scabiei, or any of various ticks; also applied to objects such as furniture and bedding.

permethrin

(pər-mĕth′rĭn)
n.
A synthetic pyrethroid, C21H20Cl2O3, used as an agricultural, industrial, and residential insecticide, to treat scabies and head lice in humans, and to control fleas and ticks in dogs.

permethrin

[pərməth′rin]
a topical pediculicide and scabicide.
indications It is used for the treatment of head lice and their nits, for the treatment of scabies, and as prophylaxis when there are epidemics of lice.
contraindications Allergies to pyrethrin, pyrethroids, or chrysanthemum flowers prohibit its use.
adverse effects Among reported adverse effects are itching, mild burning or stinging, numbness, discomfort, mild erythema, and scalp rash.

permethrin

Acticin® Infectious disease A topical insecticide used for scabies and head lice. See Head lice, Scabies.

permethrin

A drug used externally in a hair rinse to get rid of head lice. The drug is on the WHO official list. A brand name is Lyclear.

Permethrin

A medication used to rid the scalp of head lice. Permethrin works by paralyzing the lice, so that they cannot feed after hatching within the 24 hours required for survival.
Mentioned in: Lice Infestation

permethrin

; Lyclear topical scabies treatment

permethrin

a third-generation synthetic pyrethroid widely used in the control of ectoparasites. It is very stable and lasts for several weeks.
References in periodicals archive ?
Under the terms of the agreement, Alpharma will manufacture and supply the product to Penederm, which will pay Alpharma milestones and royalties based upon Acticin sales and profits.
The first quarter of 1998 reflects product revenues from Avita cream and Mentax and initial product stocking shipments of the Company's recently launched Acticin and Avita gel products.
We launched to the trade our two newest products, Acticin and Avita gel, made substantial progress toward the final completion of our two pivotal phase III human clinical studies of the 501 cream product, and completed the vast majority of our transition to an employee-based, internally managed sales force.